Effect of siRNA targeting MTA1 on metastasis malignant phenotype of ovarian cancer A2780 cells

Abstract

Ovarian cancer is the fifth lethal gynecologic malignancy. Metastasis-associated gene 1 (MTA1) is overexpressed in many malignant tumors with high metastatic potential. This study investigated whether down-regulation of MTA1 expression by RNAi in A2780 ovarian cancer cells could affect proliferation, anoikis, migration, invasion and adhesion of the cells and to research the potential for MTA1 gene therapy of ovarian cancer. After transfection with effective Mta1 gene siRNA, the effects on proliferation, anoikis, migration, invasion and adhesion of A2780 cells were tested by MTT assay, flow cytometry, wound-healing assay, Transwell assay and adhesion assay. Expression levels of PTEN, beta 1 integrin, MMP-9, phosphor-AKT (Ser473), and total AKT activity were evaluated in control and transfected cells. The results showed that inhibition of MTA1 mediated by Mta1-siRNA transfection decreased the cell invasion, migration and adhesion, and induced the increased cell anoikis, but no significant difference was found in proliferation of A2780 cancer cells. In addition, beta 1 integrin, MMP-9, and phosphor-AKT protein levels were significantly down-regulated, while PTEN was significantly up-regulated. These results demonstrated that MTA1 played an important role in the cell metastasis in ovarian cancer. MTA1 could serve as another novel potential therapeutic target in ovarian cancer.

Keywords

metastasis-associated gene 1 / ovarian cancer / invasion / migration / anoikis

References

[1] NaoraH, MontellDJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer, 2005, 5(5): 355-366

[2] BurgesA, SchmalfeldtB. Ovarian cancer: diagnosis and treatment. Dtsch Arztebl Int, 2011, 108(38): 635-641

[3] TohY, PencilSD, NicolsonGL. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem, 1994, 269(37): 22958-22963

[4] LiDQ, PakalaSB, NairSS, et al.. Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Res, 2012, 72(2): 387-394

[5] TohY, NicolsonGL. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis, 2009, 26(3): 215-227

[6] RaoY, WangH, FanL, et al.. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/beta-catenin complex. J Huazhong Univ Sci Technolog Med Sci, 2011, 31(1): 1-9

[7] MartinMD, HilsenbeckSG, MohsinSK, et al.. Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Res Treat, 2006, 95(1): 7-12

[8] SasakiH, MoriyamaS, NakashimaY, et al.. Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer, 2002, 35(2): 149-154

[9] PriscoMG, ZannoniGF, De StefanoI, et al.. Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study. Hum Pathol, 2012, 43(2): 282-288

[10] KandalaPK, SrivastavaSK. Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo. J Biol Chem, 2012, 287(34): 28 745-28 754

[11] LengyelE. Ovarian cancer development and metastasis. Am J Pathol, 2010, 177(3): 1053-1064

[12] ChenJ, LiZ, ZhangS, et al.. Effects of exogenous VEGF(165)b on invasion and migration of human lung adenocarcinoma A549 cells. J Huazhong Univ Sci Technol Med Sci, 2011, 31(5): 619-624

[13] TohY, OkiE, OdaS, et al.. Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer, 1997, 74(4): 459-463

[14] TohY, KuwanoH, MoriM, et al.. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer, 1999, 79(11–12): 1723-1726

[15] KiddM, ModlinIM, ManeSM, et al.. The role of genetic markers-NAP1L1, MAGE-D2, and MTA1—in defining small-intestinal carcinoid neoplasia. Ann Surg Oncol, 2006, 13(2): 253-262

[16] BalasenthilS, BroaddusRR, KumarR. Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Hum Pathol, 2006, 37(6): 656-661

[17] DannenmannC, ShabaniN, FrieseK, et al.. The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther, 2008, 7(9): 1460-1467

[18] NawaA, NishimoriK, LinP, et al.. Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J Cell Biochem, 2000, 79(2): 202-212

[19] QianH, LuN, XueL, et al.. Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line. Clin Exp Metastasis, 2005, 22(8): 653-662

[20] GubbelsJA, ClaussenN, KapurAK, et al.. The detection, treatment, and biology of epithelial ovarian cancer. J Ovarian Res, 2010, 3: 8

[21] YangZ, YiJ, LiX, et al.. PTEN induces anoikis through its phosphatase activity in hepatocellular carcinoma cells. Zhonghua Zhongliu Zazhi (Chinese), 2005, 27(5): 273-275

[22] WuH, WangS, WengD, et al.. Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene. Cancer Lett, 2008, 271(2): 205-214

[23] BeausejourM, NoelD, ThibodeauS, et al.. Integrin/ Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes. Apoptosis, 2012, 17(6): 566-578

[24] LottiR, MarconiA, TruzziF, et al.. A previously unreported function of beta(1)B integrin isoform in caspase-8-dependent integrin-mediated keratinocyte death. J Invest Dermatol, 2010, 130(11): 2569-2577

[25] SeinTT, ThantAA, HiraiwaY, et al.. A role for FAK in the Concanavalin A-dependent secretion of matrix metalloproteinase-2 and -9. Oncogene, 2000, 19(48): 5539-5542

[26] MengQ, XiaC, FangJ, et al.. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal, 2006, 18(12): 2262-2271

[27] LessanK, AguiarDJ, OegemaT, et al.. CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol, 1999, 154(5): 1525-1537

[28] StrobelT, CannistraSA. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol, 1999, 73(3): 362-367